Immuron Limited Banner Image

Immuron Limited

  • Ticker IMRN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Immuron Limited Logo Image
  • 11-50 Employees
  • Based in Melbourne, Australia
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.
Immuron Limited

Most Recent Annual Report

Immuron Limited
MOST RECENT 2020 Annual Report

Older/Archived Annual Reports